Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing precisely hydrocodone bitartrate 10 milligram and paracetamol 300 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely hydrocodone bitartrate 10 milligram and paracetamol 300 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
Ranolazine 500 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
vareniclin 1 mg tablet |
Has presentation strength numerator value |
False |
en |
Inferred relationship |
Some |
1 |
vareniclin 1 mg tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
rosiglitazon 2 mg tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Tadalafil 5 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
paroxetin 40 mg tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Oxycodone hydrochloride 7.5 mg and paracetamol 400 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Oxycodone hydrochloride 7.5 mg and paracetamol 400 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
Oxycodone hydrochloride 10 mg and paracetamol 500 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Oxycodone hydrochloride 10 mg and paracetamol 500 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
Lenalidomide 5 mg oral capsule |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
levothyroxinnatrium 150 µg, kapsel |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Saquinavir (as saquinavir mesilate) 200 mg oral capsule |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Lamivudine 150 mg and nevirapine 200 mg and zidovudine 300 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Lamivudine 150 mg and nevirapine 200 mg and zidovudine 300 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
Lamivudine 150 mg and nevirapine 200 mg and zidovudine 300 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
3 |
Telbivudine 600 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
saquinavirmesylat 500 mg tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
levothyroxinnatrium 75 µg, kapsel |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Vorinostat 100 mg oral capsule |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Sitagliptin (as sitagliptin phosphate) 25 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Oxymorphone 5 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
rosiglitazon 4 mg + glimepirid 2 mg tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
rosiglitazon 4 mg + glimepirid 2 mg tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
Oxymorphone 10 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
levothyroxinnatrium 50 µg, kapsel |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Sitagliptin (as sitagliptin phosphate) 100 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
rosiglitazon 4 mg + glimepirid 4 mg tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
rosiglitazon 4 mg + glimepirid 4 mg tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
levothyroxinnatrium 25 µg, kapsel |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely sitagliptin (as sitagliptin phosphate) 50 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
levothyroxinnatrium 100 µg, kapsel |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
rosiglitazon 4 mg + glimepirid 1 mg tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
rosiglitazon 4 mg + glimepirid 1 mg tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
Levothyroxine sodium 125 microgram oral capsule |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
tablet sitagliptin 50 mg + metformin 1000 mg |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
tablet sitagliptin 50 mg + metformin 1000 mg |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
Phentermine resin 30 mg oral capsule |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Lamivudine 150 mg and stavudine 40 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Lamivudine 150 mg and stavudine 40 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
Risedronate sodium 75 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
sitagliptin 50 mg + metformin 500 mg tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
sitagliptin 50 mg + metformin 500 mg tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
lapatinib 250 mg tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely oxycodone hydrochloride 2.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely oxycodone hydrochloride 2.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
Product containing precisely lisdexamfetamine dimesylate 50 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Lisdexamfetamine dimesylate 30 mg oral capsule |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Pafuramidine maleate 100 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Lisdexamfetamine dimesylate 70 mg oral capsule |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Ribavirin 600 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
topotecan 1 mg, kapsel |
Has presentation strength numerator value |
False |
en |
Inferred relationship |
Some |
1 |
topotecan 1 mg, kapsel |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
ropinirol 500 µg tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
valacyclovir 1 g, tablet |
Has presentation strength numerator value |
False |
en |
Inferred relationship |
Some |
1 |
valacyclovir 1 g, tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely quinine sulfate 324 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
topotecan 0,25 mg, kapsel |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Vildagliptin 100 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Maraviroc 150 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Vildagliptin 50 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Sevelamer carbonate 800 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Lamivudine 150 mg and stavudine 30 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Lamivudine 150 mg and stavudine 30 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
ropinirol 3 mg tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Maraviroc 300 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
raltegravir 400 mg tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely quetiapine fumarate 400 milligram/1 each conventional release oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely quetiapine (as quetiapine fumarate) 300 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely vardenafil hydrochloride 2.5 milligram/1 each conventional release oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Temazepam 22.5 mg oral capsule |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Risedronate sodium 150 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely lisdexamfetamine dimesylate 20 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Lisdexamfetamine dimesylate 40 mg oral capsule |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely lisdexamfetamine dimesylate 60 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Lopinavir 100 mg and ritonavir 25 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Lopinavir 100 mg and ritonavir 25 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
Product containing precisely sapropterin dihydrochloride 100 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Levomefolic acid 7.5 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely hydrocodone bitartrate 5 milligram and paracetamol 400 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely hydrocodone bitartrate 5 milligram and paracetamol 400 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
Tadalafil 2.5 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Polythiazide 4 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Tetrabenazine 12.5 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely hydrocodone bitartrate 7.5 milligram and paracetamol 400 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely hydrocodone bitartrate 7.5 milligram and paracetamol 400 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
2 |
Product containing precisely sodium iodide (123-I) 7.4 megabecquerel/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Metformin hydrochloride 500 mg and repaglinide 1 mg oral tablet |
Has presentation strength numerator value |
False |
en |
Inferred relationship |
Some |
2 |
Lacosamide 100 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Rufinamide 200 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely quetiapine fumarate 50 milligram/1 each conventional release oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely silodosin 8 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely silodosin 4 milligram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Rufinamide 400 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Lacosamide 200 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Lacosamide 150 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Lacosamide 50 mg oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely tapentadol (as tapentadol hydrochloride) 75 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |
Product containing precisely tapentadol hydrochloride 100 milligram/1 each conventional release oral tablet |
Has presentation strength denominator value |
False |
en |
Inferred relationship |
Some |
1 |